Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Barbara E. Epremian"'
Publikováno v:
Critical Reviews in Oncology/Hematology. 7:71-87
Myelotoxicity remains a significant dose-limiting side effect of chemotherapy contributing to the morbidity and mortality of patients undergoing treatment for cancer. A number of different experimental approaches are being studied, both in the clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7edf1aab3725bce76391fd410f634846
https://doi.org/10.1016/s1040-8428(87)80015-x
https://doi.org/10.1016/s1040-8428(87)80015-x
Publikováno v:
American Journal of Clinical Pathology. 91:31-36
The authors have used two immunoalkaline phosphatase methods to study nonhematopoietic tumor tissues of four patients, one each with alveolar cell carcinoma of the lung, renal cell carcinoma, gastric adenocarcinoma, and colon carcinoma. They found, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64222515f61045070b0d72a77855bcd0
https://doi.org/10.1093/ajcp/91.1.31
https://doi.org/10.1093/ajcp/91.1.31
Autor:
Barbara E. Epremian, Baby Jose, Eliza J. Sherrill, Stephen P. Richman, Martin S. Blumenreich, Thomas M. Woodcock, Patrick S. Gentile, George R. Barnes, Joseph C. Allegra, Thomas T. Kubota
Publikováno v:
Journal of Clinical Oncology. 5:1725-1730
Non-small-cell lung cancer (NSCLC) patients with locally advanced or metastatic measurable disease were given a combination of cisplatin, 200 mg/m2 divided in five daily doses, and simultaneously, vinblastine, 7.5 mg/m2 as a continuous intravenous (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e82a8e995ebd6d8c2b7e1f8dd91b9f
https://doi.org/10.1200/jco.1987.5.11.1725
https://doi.org/10.1200/jco.1987.5.11.1725
Publikováno v:
Journal of Histotechnology. 10:127-130
We report a case of chronic lymphocytic leukemia in prolymphocytic transformation. Although the clinical findings in this patient were similar to those of some cases of hairy cell leukemia, many of the leukemic cells were morphologically typical of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::617c3e03435b4f1d175456ea29cb3ba2
https://doi.org/10.1179/his.1987.10.2.127
https://doi.org/10.1179/his.1987.10.2.127
Autor:
Thomas T. Kubota, Barbara E. Epremian, Thomas M. Woodcock, Joseph C. Allegra, Patrick S. Gentile, Martin S. Blumenreich, Eliza J. Sherrill, Stephen P. Richman
Publikováno v:
Cancer Investigation. 6:371-375
We carried out a phase I trial with chlorambucil. Thirty patients with advanced cancer were entered in six dose levels: 36, 48, 60, 84, 108, and 144 mg/m2. The drug was given in six divided oral doses every 6 hours and the regimen was repeated every
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f51f86854e5ae1c995e82c62e7cc25e
https://doi.org/10.3109/07357908809080064
https://doi.org/10.3109/07357908809080064
Publikováno v:
American journal of clinical oncology. 11(6)
Twenty-two patients with metastatic melanoma were treated with a chemotherapy regimen consisting of two cycles of induction therapy with vinblastine, bleomycin, and cisplatin, followed by maintenance therapy with dacarbazine and dibromodulcitol. A 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::808e3d566b14bcf0570736a075a25944
https://pubmed.ncbi.nlm.nih.gov/2461074
https://pubmed.ncbi.nlm.nih.gov/2461074
Autor:
Barbara E. Epremian, John T. Hamm, Thomas M. Woodcock, Martin S. Blumenreich, Patrick S. Gentile, Janell Seeger, Eliza J. Sherrill, Subhash P. Sheth, Joseph C. Allegra
Publikováno v:
American Journal of Clinical Oncology. 10:515-516
A Phase II trial of high-dose chlorambucil at 108 mg/m2 was undertaken in non-small cell lung cancer. No complete or partial objective responses were observed, and significant toxicity, including nausea, vomiting, and seizures, was noted. Chlorambuci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c60c804e8b63e02d49eb75aee830f74
https://doi.org/10.1097/00000421-198712000-00011
https://doi.org/10.1097/00000421-198712000-00011